These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15625860)

  • 41. Structure activity studies on somatostatin.
    Sarantakis D; McKinley WA; Jaunakais I; Clark D; Grant NH
    Clin Endocrinol (Oxf); 1976; 5 Suppl():275S-278S. PubMed ID: 1052780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of iodinated somatostatin analogues selective for hsst2 and hsst5 with excellent inhibition of growth hormone and prolactin release from rat pituitary cells.
    Moore SB; van der Hoek J; de Capua A; van Koetsveld PM; Hofland LJ; Lamberts SW; Goodman M
    J Med Chem; 2005 Oct; 48(21):6643-52. PubMed ID: 16220980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective inhibition of sleep related growth hormone release by Phe-4-somatostatin.
    Cabranes JA; Vela A; Timoneda F; Meyers CA; Coy DH; Schally AV; Charro AL
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):421-31. PubMed ID: 6150528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Superactive somatostatin analog decreases plasma glucose and glucagon levels in diabetic rats.
    Karashima T; Schally AV
    Peptides; 1988; 9(3):561-5. PubMed ID: 2901737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of somatostatin analogs on gastric acid secretion in dogs and rats.
    Schally AV; Colaluca J; Paulson D; Carter WH; Neitzschman HR; Lafaye H; Cai RZ
    Int J Pept Protein Res; 1990 Sep; 36(3):267-74. PubMed ID: 1980670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.
    Bauer W; Briner U; Doepfner W; Haller R; Huguenin R; Marbach P; Petcher TJ; Pless
    Life Sci; 1982 Sep; 31(11):1133-40. PubMed ID: 6128648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release.
    Meyers CA; Coy DH; Murphy WA; Redding TW; Arimura A; Schally AV
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):577-9. PubMed ID: 6987657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation and characterization of somatostatin from pigeon pancreas.
    Spiess J; Rivier JE; Rodkey JA; Bennett CD; Vale W
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2974-8. PubMed ID: 288081
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Somatostatin-28 is longer acting and more selective than somatostatin-14 on pituitary and pancreatic hormone release.
    Tannenbaum GS; Ling N; Brazeau P
    Endocrinology; 1982 Jul; 111(1):101-7. PubMed ID: 6123428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tyrosylated analogues of somatostatin.
    Rivier JE; Brown MR; Vale WW
    J Med Chem; 1976 Aug; 19(8):1010-3. PubMed ID: 966246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Somatostatin receptor 1 selective analogues: 2. N(alpha)-Methylated scan.
    Erchegyi J; Hoeger CA; Low W; Hoyer D; Waser B; Eltschinger V; Schaer JC; Cescato R; Reubi JC; Rivier JE
    J Med Chem; 2005 Jan; 48(2):507-14. PubMed ID: 15658864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective effect of some somatostatin analogs on glucagon as opposed to insulin release in rats in vivo.
    Lins PE; Efendić S; Meyers CA; Coy DH; Schally A; Luft R
    Metabolism; 1980 Aug; 29(8):728-31. PubMed ID: 6105610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prolonged suppression of pituitary and pancreatic hormone release by a somatostatin analog.
    Lien EL; Fenichel RL; Grant NH; Boxill GC; Greenwood J; Yardley JP
    Biochem Biophys Res Commun; 1977 Aug; 77(4):1317-25. PubMed ID: 143285
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on the mechanism of somatostatin action on insulin release. III. Effect of somatostatin on arginine induced release of insulin and glucagon in man and perfused rat pancreas.
    Efendić S; Claro A; Laft R
    Acta Endocrinol (Copenh); 1976 Apr; 81(4):753-61. PubMed ID: 946565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory action of somatostatin on pancreatic alpha and beta cell function.
    Leblanc H; Anderson JR; Sigel MB; Yen SS
    J Clin Endocrinol Metab; 1975 Apr; 40(4):568-72. PubMed ID: 1092707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of arginine aspartate and its components on growth hormone, insulin and glucagon secretion in the rat.
    Franchimont P; Campistron G; Creuzet MH; Gros J; Luyckx A
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):161-8. PubMed ID: 6372719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of cylic and linear forms of somatostatin in the inhibiton of growth hormone, insulin and glucagon Secretion.
    Leblanc H; Yen SS
    J Clin Endocrinol Metab; 1975 May; 40(5):906-8. PubMed ID: 1127098
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glucagon releasing activity of a cyclic peptide related to somatostatin.
    Lyle TA; Freidinger RM; Nutt RF; Homnick CF; Saperstein R; Veber DF
    Int J Pept Protein Res; 1987 Feb; 29(2):244-9. PubMed ID: 2883151
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Somatostatin agonists and antagonists--peptide control of growth hormone secretion.
    Coy DH; Murphy WA; Lance VA; Hocart SJ; Sueiras-Diaz J; Mezo I
    Adv Exp Med Biol; 1985; 188():325-37. PubMed ID: 2863940
    [No Abstract]   [Full Text] [Related]  

  • 60. Development of specific and non-specific somatostatin analogs.
    Nakano T; Harano Y; Emura J; Kimura T; Sakakibara S; Shigeta Y
    Horm Metab Res; 1986 Feb; 18(2):98-102. PubMed ID: 2870971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.